Global Cholera Vaccine Market Research Report And Future Outlook: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit According to a new report published by Allied Market Research, titled, “Cholera Vaccine Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025,” the global cholera vaccine market generated USD 65 million in 2017, and is projected to reach USD 207 million by 2025, growing at a CAGR of 15.6% from 2018 to 2025. The Dukoral segment accounted around half of the total market share in 2017. Cholera is an acute, profusely watery diarrhea caused by Vibrio cholera and spreads through contamination of water and food. In addition, it is closely associated with poor sanitation and lack of clean drinking water. The number of global cholera disease cases accounts for around 35 million every year. Currently, the frequency of cholera epidemics has increased mainly in low- and middle-income countries. Cholera control is the main priority in cholera-endemic areas, which in turn increase the demand for the cholera vaccines. The cholera vaccine market is expected to exhibit significant growth during the forecast period due to lack of proper sanitation & consumption of contaminated food and growth in awareness about cholera preventive care. In addition, development of novel approaches for new cholera vaccine further drive the market growth. However, risk of adverse effects and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, high growth opportunities in untapped markets are expected to offer significant profitable opportunities for the market players in the near future. Based on end user, the market is categorized into hospitals & clinics, research & academic laboratories, and others. The hospitals & clinics segment presently dominates the market, and is expected to remain dominant during the forecast period. This is attributed to the fact that hospitals and clinics are authorized to organize campaigns for cholera vaccination, as the number of cases for cholera diseases is rapidly growing in LMICs. Asia-Pacific was the leading revenue contributor to the global cholera vaccine market in 2017, and is expected to remain dominant throughout the forecast period due to increase in the prevalence of cholera disease and rise in importance of immunization. However, North America is expected to grow at the highest CAGR during the study period. This is attributed to the launch of the first and only oral cholera vaccine, Vaxchora, in the USA. Furthermore, the number of travelers to the cholera-affected countries is increasing, which in turn increases the demand for immunization. The report provides a comprehensive analysis of the key players operating in the global cholera vaccine market namely Valneva SE, Emergent BioSolutions, Inc. (PaxVax, Inc.), Astellas Pharma, Inc., Sanofi (Shantha Biotechnics Private Limited), Eubiologics Co., Ltd., and Johnson & Johnson (Crucell), Celldex Therapeutics, Inc. The other players in the in the cholera vaccine market industry include Merck & Co., Inc., GlaxoSmithKline plc., and others. Based on product, the Vaxchora segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 17.4% from 2018 to 2025. Depending on end user, the pharmaceutical & biotechnology companies segment is expected to exhibit the highest CAGR during the forecast period. U.S. generated the highest revenue in the global cholera vaccine market industry in 2017, accounting less than one-tenth of the global market in 2017. North America is estimated to grow at a CAGR of 17.1% during the forecast period. For more information on the research report, refer to below link:- Global Cholera Vaccine Market Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Post Views: 6 Tags: Asia Pacific Cholera Vaccine Market, Astellas Pharma Cholera Vaccine Market Revenue, Australia Cholera Vaccine Market, Canada Cholera Vaccine Market, Celldex Therapeutics Cholera Vaccine Market Shares, China Cholera Vaccine Market, Cholera Vaccine Industry In Global, Cholera Vaccine Market In Global, Emergent BioSolutions Cholera Vaccine Market Size, Eubiologics Cholera Vaccine Market Revenue, Europe Cholera Vaccine Market, Germany Cholera Vaccine Market, GlaxoSmithKline Cholera Vaccine Market Shares, Global Academic Laboratories Cholera Vaccine Market, Global Cholera Vaccine Industry, Global Cholera Vaccine Industry Research Report, Global Cholera Vaccine Market, Global Cholera Vaccine Market Analysis, Global Cholera Vaccine Market Competition, Global Cholera Vaccine Market Forecast, Global Cholera Vaccine Market Future Outlook, Global Cholera Vaccine Market Growth, Global Cholera Vaccine Market Research Report, Global Cholera Vaccine Market Revenue, Global Cholera Vaccine Market Shares, Global Cholera Vaccine Market Size, Global Cholera Vaccine Market Trends, Global Clinics Cholera Vaccine Market, Global Dukoral Cholera Vaccine Market, Global Euvichol Cholera Vaccine Market, Global Euvichol Plus Cholera Vaccine Market, Global Hospitals Cholera Vaccine Market, Global Research Cholera Vaccine Market, Global Shanchol Cholera Vaccine Market, Global Vaxchora Cholera Vaccine Market, India Cholera Vaccine Market, Industry Research Report Of Global Cholera Vaccine, Italy Cholera Vaccine Market, Japan Cholera Vaccine Market, Johnson & Johnson (Crucell) Cholera Vaccine Market Size, Marché mondial des vaccins contre le cholera, Market Research Report Of Global Cholera Vaccine, Mercado mundial de vacunas contra el cólera, Merck & Co. Cholera Vaccine Market Size, Mexico Cholera Vaccine Market, Nigeria Cholera Vaccine Market, North America Cholera Vaccine Market, Pasar Vaksin Kolera Global, Sanofi (Shantha Biotechnics) Cholera Vaccine Market Size, Sweden Cholera Vaccine Market, U.S Cholera Vaccine Market, UK Cholera Vaccine Market, Valneva SE Cholera Vaccine Market Shares, Vietnam Cholera Vaccine Market, Zambia Cholera Vaccine Market, Глобальний ринок вакцини проти холери, Глобальный рынок вакцин против холеры, السوق العالمي للقاحات الكوليرا, ตลาดวัคซีนอหิวาตกโรคสากล, 世界のコレラワクチン市場, 全球霍乱疫苗市场, 세계적인 콜레라 백신 시장